Bush signs law banning certain steroid-like drugs

	Tweet

President Bush signed a law on Friday banning certain steroid-like drugs, used by some athletes as performance enhancers.

The new law adds 18 substances to the list of banned anabolic steroids, including androstenedione, also known as “andro,” which was made famous by baseball slugger Mark McGwire in the 1990s.

When injected, these substances metabolize into testosterone or other illicit steroids, and federal regulators have been seeking to crack down on the makers of these drugs.

“Steroid use by young people is a serious health issue,” said Sen. Joseph Biden, who crafted the measure.

“This new law sends a strong message about andro and other steroid precursors. We are calling them what they really are: drugs, performance enhancing drugs,” the Democrat from Delaware said.

The newly signed “Anabolic Steroid Control Act of 2004,” also requires a review of federal sentencing guidelines for offenses involving anabolic steroids. It calls for criminal penalties for those caught making, selling or possessing the substances.

The new law also provides $15 million for education programs to teach children about the dangers of steroids.

RELATED STORIES:
Lawsuit claims Glaxo hid Paxil findings   Measures how to clamp down on Internet pharmacies   Nosespray Vaccine Using Aloe Vera Has Exciting Potential   Putting an old drug to a new use   FDA approves deep wrinkle filler   Canada’s first prescription drug atlas maps billions in spending   Pfizer acquires worldwide rights to Exubera   FDA approves AbioCor permanent artificial heart for humanitarian uses   Alfuzosin safe for older patients with cardiovascular disease   Cialis impotence drug returns to Super Bowl   UK to save on generic medicines bill   Buying drugs online can be risky - report

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]